Pirouette Pharma key facts
as of Oct 2026- Developer of automated injectors designed for the emergency treatment of severe allergic reactions.
- Pirouette Pharma is valued at approximately $95.0M as of Oct 2026, set at its Equity Crowdfunding, Feb 2026; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $22.9M across 2 recorded rounds; the latest was Seed Round ($1.1M) in Mar 2026.
- Notable investors include Y Combinator, Gaingels, Liquid 2 Ventures, Asymmetry Ventures, 515 Ventures — 20 tracked in total.
- Pirouette Pharma has filed 1 Form D with the SEC, most recently Apr 2025 ($2.4M sold to 1 investors).
- Status: Privately Held (backing).
Valued at $95.0M at its Equity Crowdfunding, Feb 2026. Nothing has traded since.
- ·The complete investor list: 20 names
- ·Watch Pirouette Pharma: the Monday email on marks, rounds and moves
Pirouette Pharma funding rounds
2 roundsWho backs Pirouette Pharma
20+Membership and data by Private Market View
Pirouette Pharma valuation
Pirouette Pharma was valued at $95 million at its Equity Crowdfunding in Feb 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Pirouette Pharma raised?
Pirouette Pharma has raised $22.9 million in total; 2 of its rounds are on record. The largest on record was a $2.4 million seed round in Mar 2025; the most recent was a $1.1 million seed round in Mar 2026.
Pirouette Pharma has filed 1 Form D with the SEC, most recently in Apr 2025 ($2.4 million sold to 1 investor).
Pirouette Pharma investors
20 investors are on record for Pirouette Pharma, including Y Combinator, Gaingels, Liquid 2 Ventures and Asymmetry Ventures. By type, the record holds 4 venture capital firms and 1 hedge fund. The seed round in Mar 2026 drew 1 investor.
About Pirouette Pharma
Developer of automated injectors designed for the emergency treatment of severe allergic reactions. The company's injectors are portable and intuitive and address all the major pain points through a human-centered design that focuses on auto-injector places healthcare in the hands of the patient, where the improved patient experience is built on increased access, enabling healthcare industries to diversely apply drugs that require fixed-dose, single-use intramuscular or subcutaneous injections.
- Sector
- Healthcare
- HQ
- Portsmouth, NH, United States
- Founded
- 2017
- Employees
- 29
- Website
- pirouettepharma.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.